← Back to Search

Mepilex Ag (burn dressing) for Burns

N/A
Waitlist Available
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up burn injury healing time; up to 10 weeks
Awards & highlights

Study Summary

This trial is testing whether Mepilex Ag, a more expensive burn dressing, is better than Xeroform for healing partial thickness burns in pediatric patients. The study will look at healing time, scar appearance, and patient pain and comfort during treatment and dressing changes.

Eligible Conditions
  • Burns

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~burn injury healing time; up to 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and burn injury healing time; up to 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Scar Evaluation
Secondary outcome measures
Dressing Change Survey

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mepilex Ag InterventionExperimental Treatment1 Intervention
A single wound is treated with both the control (xeroform dressing) and intervention (Mepilex Ag). Approximately 50% of the wound is treated with Mepilex Ag; the product being tested.
Group II: Xeroform ControlActive Control1 Intervention
A single wound is treated with both the control (xeroform dressing) and intervention (Mepilex Ag). Approximately 50% of the wound is treated with xeroform dressing, which is the standard of care.

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
307 Previous Clinical Trials
108,483 Total Patients Enrolled
Elika Ridelman, PhDStudy Director - Wayne State University
Wayne State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025